Tymoniuk Bogusław, Borowiec Maciej, Makowska Joanna, Holwek Emilia, Sarnik Joanna, Styrzyński Filip, Dróżdż Izabela, Lewiński Andrzej, Stasiak Magdalena
Department of Immunology and Allergy, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland.
Department of Clinical Genetics, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland.
J Clin Med. 2024 Dec 17;13(24):7695. doi: 10.3390/jcm13247695.
: Severe COVID-19 still constitutes an important health problem. Taking into account the crucial role of HLA in immune reactions, evaluation of the impact of HLA on COVID-19 risk and clinical course seemed necessary, as the already available data are inconsistent. The aim of the present study was to compare the HLA profiles of patients with symptomatic SARS-CoV-2 infection and a healthy control group, as well as to compare HLA allele frequencies in patients with severe and non-severe courses of COVID-19. : HLA classes were genotyped using a next-generation sequencing method in 2322 persons, including 2217 healthy hematopoietic stem cell potential donors and 105 patients with symptomatic COVID-19. : Symptomatic course of SARS-CoV-2 infection appeared to be associated with the presence of , , , , , and , while and seem to play a protective role. Moreover, we demonstrated that the severe symptomatic course of COVID-19 can be associated with the presence of , , , and , while HLA- appeared to be protective against severe COVID-19 disease. : Identification of alleles that are potentially associated with symptomatic SARS-CoV-2 infection as well as the severe course of COVID-19 broadens the knowledge on the genetic background of COVID-19 course and can constitute an important step in the development of personalized medicine.
重症新型冠状病毒肺炎(COVID-19)仍然是一个重要的健康问题。鉴于人类白细胞抗原(HLA)在免疫反应中的关键作用,由于现有数据并不一致,评估HLA对COVID-19风险和临床病程的影响似乎很有必要。本研究的目的是比较有症状的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染患者与健康对照组的HLA谱,以及比较COVID-19重症和非重症病程患者的HLA等位基因频率。使用下一代测序方法对2322人进行HLA分型,其中包括2217名健康造血干细胞潜在供者和105名有症状的COVID-19患者。SARS-CoV-2感染的有症状病程似乎与 、 、 、 、 和 的存在有关,而 和 似乎起到保护作用。此外,我们证明COVID-19的重症有症状病程可能与 、 、 和 的存在有关,而HLA- 似乎对重症COVID-19疾病有保护作用。鉴定可能与有症状的SARS-CoV-2感染以及COVID-19重症病程相关的等位基因,拓宽了对COVID-19病程遗传背景的认识,并且可能是个性化医疗发展中的重要一步。